Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00773942
Other study ID # 2007-0305
Secondary ID HHSA290200500381
Status Completed
Phase N/A
First received
Last updated
Start date November 2007
Est. completion date January 2010

Study information

Verified date July 2019
Source University of Illinois at Chicago
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if a medication therapy management program designed to reconcile a patient's medications and identify and resolve drug related problems can reduce adverse drug events and other measures of safety and improve patient satisfaction.


Description:

This study will be a multicenter, prospective, randomized study of usual care (Arm 1; control group) compared with usual care plus medication reconciliation by patient interview and a drug related problem assessment (Arm 2; Basic MTM) and usual care plus medication reconciliation by patient interview with additional information obtained from the patient chart and drug related problem assessment (Arm 3; Enhance MTM). Approximately 600 patients will be enrolled in this study, 200 in each study arm. Two hundred potential subjects will be recruited at each of the three participating sites: the UIC Medical Center, Baylor Health Care System, and Duke Primary Care Research Consortium. For inclusion in the study, patients must be at least 65 years old, primarily uses English for written and oral communication, have 3 or more comorbid conditions from a list of conditions (see table 1 of protocol), have two or more physician office visits at one or more affiliated clinics in the past year, have received 8 or more different chronic prescription medications over the six months prior to the enrollment period, have a telephone line and agree to maintain if for at least 6 months, and have a situation placing him/her at risk for a drug related problem (see protocol for list). Subjects unable to demonstrate comprehension of the informed consent, with a terminal condition, or those enrolled in an MTM program where medication reconciliation and/or assessment of drug related problems has occurred in the previous 12 months will be excluded from enrolling in the study.

Patients in the control group will participate in the baseline study visit, will continue to have access to the regular scheduled physician clinic visit and their prescription filled at the UIC pharmacy, and will participate in the telephone survey after the sixth month of the study. Patients in the Arms 2 and 3 intervention groups will participate in the baseline visit, will be asked to participate in two clinic visits with an MTM clinician, and will be asked to answer two telephone surveys (at 3 months and at 6 months after enrollment).


Recruitment information / eligibility

Status Completed
Enrollment 637
Est. completion date January 2010
Est. primary completion date January 2010
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria:

- Be at least 65 years old at enrollment

- Primarily uses English language for written and oral communication

- Have three or more comorbid conditions associated with increased healthcare utilization (Diabetes Mellitus, Congestive Heart Failure, Asthma, Hypertension, Dyslipidemia, COPD, Coronary Artery Disease, Chronic Renal Failure, Arthritis, Depression, Dementia, Chronic Pain, Conditions requiring anticoagulation with warfarin)

- Have visited a physician at one or more of the clinics on a regular basis (defined as two or more clinic visits over one year prior to the study start) for these conditions

- Have received 6 or more different chronic prescription medications over the six months prior to the enrollment period

- Have a telephone line and agree to maintain it for at least six months

- Have one of the following situations placing him/her at risk for a DRP (Any ER visit in past 30 days or Urgent Care visit in past 30 days leading to a change in medication or change in medication dose; New physician visit in past 30 days; Hospitalization in past 30 days; Invasive procedure (a procedure requiring substantive changes to medication taking practices or which requires informed consent) in past 30 days; Change in medication in past 30 days; Three or more providers seen in the past year

Exclusion Criteria:

- Terminal condition, where life expectancy is less than 6 months

- Patients already enrolled in an MTM program where medication reconciliation and/or assessment of DRPs has occurred in the previous 12 months

Study Design


Intervention

Behavioral:
Basic medication therapy management
Subjects in this arm will receive medication reconciliation and drug related problem assessment by a medication therapy management clinician utilizing patient interview alone.
Enhanced medication therapy management
Subjects in this arm will receive medication reconciliation and drug related problem assessment by a medication therapy management clinician utilizing patient interview and chart information.

Locations

Country Name City State
United States University of Illinois at Chicago Chicago Illinois
United States Baylor Health Care System Dallas Texas
United States Duke University Health System Durham North Carolina

Sponsors (5)

Lead Sponsor Collaborator
University of Illinois at Chicago Agency for Healthcare Research and Quality (AHRQ), Baylor Research Institute, Duke University, RTI International

Country where clinical trial is conducted

United States, 

References & Publications (1)

Masica AL, Touchette DR, Dolor RJ, Schumock GT, Kliethermes MA, Rodgers PT, Craft JL, Choi Y-K, Lux LJ, Smith SR. Evaluation of a medication therapy management program in Medicare beneficiaries at high risk of adverse drug events: study methods. Advances in Patient Safety. Volume 4 / Technology and Medication Safety (AHRQ 08-0034-4) http://www.ahrq.gov/qual/advances2/#v1

Outcome

Type Measure Description Time frame Safety issue
Primary Adverse Drug Events ADEs will be assessed via patient telephone interview using a tool modified from Jarernsiripornkul et al 3 and 6 months
Secondary Emergency department visits The number of ED visits collected by a blinded study investigator 180 days via patient self report obtained during a telephone interview 6 months
Secondary Hospitalizations The number of hospitalizations collected by a blinded study investigator 180 days via patient self report obtained during a telephone interview 6 months
Secondary Drug related problems The number and types of DRPs will be collected from form completed by MTM clinician 3 and 6 months
Secondary Discrepancies in medication list, intervention arms compared with best possible medication history Differences observed in MTM intervention medication list and a "Best Possible Medication History," as developed by a formal process and conducted by a study investigator. 6 months
Secondary Patient satisfaction with care. Patient self-reported satisfaction with care, obtained using the Pharmacutical Care Questionnaire administered via telephone interview. Overall satisfaction of care assessed using a 3-item questionnaire administered during telephone interview. 6 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06025071 - Residual Inflammatory Risk-Guided colcHicine in Elderly Trial Phase 4
Recruiting NCT05939674 - Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam N/A
Active, not recruiting NCT01862445 - Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients
Completed NCT04065763 - Correlation of the Dural Sac Dimension With the Spread of Spinal Anesthesia
Completed NCT06174168 - The Decisiveness of MFI-11 in Predicting Complications in Patients > 65 Years Who Underwent EBUS-TBNA Under Sedation
Completed NCT05103696 - A Comparative Study of Rimazolam and Propofol Combined With Etomidate in Gastroenteroscopy in Elderly Patients N/A
Active, not recruiting NCT05603364 - Effect of Postoperative Oral Carbohydrate Administration in Total Knee Arthroplasty Elderly Patients Early Phase 1
Terminated NCT03743961 - Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia
Terminated NCT03324711 - Psychometric Validation of the "Antillanisée" Version of the Mini Mental State Examination (MMSEa) N/A
Completed NCT03211312 - Prediction Model of Cardiac Risk for Dental Extraction in Elderly Patients With Cardiovascular Diseases
Enrolling by invitation NCT04389008 - The Study of Anesthesia-related Risk Factors for Postoperative Death in Elderly Non-cardiac Surgery Patients in China
Completed NCT01851005 - Effect of Dexmedetomidine on Recovery Profiles of Elderly Patients N/A
Recruiting NCT04442412 - Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy Phase 3
Completed NCT02873533 - Modification of the Quality of Life Based on Objective Geriatric Tests N/A
Completed NCT01599676 - Citrulline, Exercise Training and Muscle Strength in the Elderly N/A
Completed NCT04209738 - Changes in Cardiovascular and Sleep Quality Parameters Under Eurythmy Therapy and Tai Chi in Comparison to Standard Care - A Substudy of the ENTAiER Trial
Recruiting NCT04321265 - Outcomes and Prognostic Factors in COVID-19
Recruiting NCT05242692 - The Effects of Subanesthetic S-ketamine on Postoperative Delirium and Cognitive Function in the Elderly Undergoing Non-cardiac Thoracic Surgery Early Phase 1
Completed NCT03868007 - Protective Effects of RIC in Elderly With Acute Ischemic Stroke Complicating Acute Coronary Syndrome N/A
Not yet recruiting NCT04254640 - Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML Phase 2